![Björn Christian Oker-Blom](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Björn Christian Oker-Blom
Direttore/Membro del Consiglio presso ELON AB
Patrimonio netto: 655 512 $ in data 30/06/2024
Profilo
Björn Christian Oker-Blom is currently the Chairman at Bjorn Oker-bloms Minne.
He also holds director positions at Måttex AB, Alted AB, AOB Förvaltning AB, Elon Group AB, Axema Access Control AB, Nya Sällskapet, Claestorps Fideikommiss AB, Disruptive Pharma AB, and Disruptive Pharma Holding AB.
In 2005, he became an Independent Director at Elon AB.
In the past, Mr. Oker-Blom served as an Independent Director at Electra Gruppen AB, a Director at Orre & Nyberg Capital AB, a Director at SIP Gear AB, and a Deputy Director at DO intressenter AB.
He graduated from the University of Stockholm.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ELON AB
1.75% | 31/12/2023 | 260 000 ( 1.75% ) | 655 512 $ | 30/06/2024 |
Posizioni attive di Björn Christian Oker-Blom
Società | Posizione | Inizio |
---|---|---|
ELON AB | Direttore/Membro del Consiglio | 01/01/2005 |
Alted AB
![]() Alted AB Investment Banks/BrokersFinance Alted AB provides management and trading services in securities. The company is based in Stockholm, Sweden. | Direttore/Membro del Consiglio | - |
AOB Förvaltning AB | Direttore/Membro del Consiglio | - |
Bjorn Oker-bloms Minne | Presidente | - |
Axema Access Control AB | Direttore/Membro del Consiglio | - |
Nya Sällskapet | Direttore/Membro del Consiglio | - |
Måttex AB | Direttore/Membro del Consiglio | - |
Disruptive Pharma Holding AB | Direttore/Membro del Consiglio | - |
Disruptive Pharma AB
![]() Disruptive Pharma AB Pharmaceuticals: MajorHealth Technology Disruptive Pharma AB is a pharmaceutical company based in Uppsala, Sweden, with a passion for innovation in drug products. The Swedish company has perfected the groundbreaking mesoporous magnesium carbonate (mmc) drug delivery technology, which makes it easier to develop amorphous drug candidates. By combining the mmc formulation technology with drug compounds, they can enhance existing products or assist in formulating new therapies. Disruptive Pharma seeks commercial partnership or licensing to industry partners within the drug improvement business area. The company was founded in 2018 by Maria Strömme, and the CEO is Peter Åsberg. | Direttore/Membro del Consiglio | 01/01/2021 |
░░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Precedenti posizioni note di Björn Christian Oker-Blom
Società | Posizione | Fine |
---|---|---|
░░░░ ░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
░░░ ░░░░ ░░ | ░░░░░░░░░░ | - |
░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Björn Christian Oker-Blom
University of Stockholm | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ELON AB | Retail Trade |
Aziende private | 14 |
---|---|
Måttex AB | |
Alted AB
![]() Alted AB Investment Banks/BrokersFinance Alted AB provides management and trading services in securities. The company is based in Stockholm, Sweden. | Finance |
Electra Gruppen AB
![]() Electra Gruppen AB Electronics/AppliancesConsumer Durables Electra Gruppen AB operates as a holding company. It operates through the following segments: Electra Retail and Electra Logistics & IT. The Electra Retail segment offers consumer electronic products, marketing, and concept development services. The Electra Logistics & IT segment focuses on third party logistics and web solutions as well as the operation of smart store computer systems. The company was founded by Gunnar Lissinger in 1949 and is headquartered in Kalmar, Sweden. | Consumer Durables |
Orre & Nyberg Capital AB
![]() Orre & Nyberg Capital AB Investment ManagersFinance Orre & Nyberg Capital AB (ONC) is an independent, boutique-sized asset management firm which is majority-owned by the partners. Minority shareholders include Alted AB, a privately-held investment company, and Purpose AB. ONC was established in 2005 and is located in Stockholm. The firm specializes in alternative investments. They manage the Radar hedge fund. Their clients are high-net worth individuals and institutions. ONC's hedge fund is closed to new investors to protect flexibility and future performances. | Finance |
AOB Förvaltning AB | |
Elon Group AB
![]() Elon Group AB Electronics/Appliance StoresRetail Trade ELON Group AB sells appliances and small electronics. The firm provides purchasing and logistics services for heavy appliances. It carries brands such as ELON, Bäcklunda, Elvita, Elis&Elsa, and Canvac. The company was founded in 2003 and is headquartered in Orebro, Sweden. | Retail Trade |
SIP Gear AB | |
DO intressenter AB
![]() DO intressenter AB Financial ConglomeratesFinance DO intressenter AB owns and manages shares and participations. The company is headquartered in Stockholm, Sweden. | Finance |
Bjorn Oker-bloms Minne | |
Axema Access Control AB | |
Nya Sällskapet | |
Claestorps Fideikommiss AB
![]() Claestorps Fideikommiss AB Agricultural Commodities/MillingProcess Industries Claestorps Fideikommiss AB provides hunting services. The private company is based in Klastorp, Sweden. | Process Industries |
Disruptive Pharma AB
![]() Disruptive Pharma AB Pharmaceuticals: MajorHealth Technology Disruptive Pharma AB is a pharmaceutical company based in Uppsala, Sweden, with a passion for innovation in drug products. The Swedish company has perfected the groundbreaking mesoporous magnesium carbonate (mmc) drug delivery technology, which makes it easier to develop amorphous drug candidates. By combining the mmc formulation technology with drug compounds, they can enhance existing products or assist in formulating new therapies. Disruptive Pharma seeks commercial partnership or licensing to industry partners within the drug improvement business area. The company was founded in 2018 by Maria Strömme, and the CEO is Peter Åsberg. | Health Technology |
Disruptive Pharma Holding AB |
- Borsa valori
- Insiders
- Björn Christian Oker-Blom